vrc-wevvlp073-00-vp
Vaccineexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 29, 2019 (NCT03879603)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Eastern equine encephalitis virusImmunity, active
immunity, active - Eastern equine encephalitis virus
- Venezuelan equine encephalitis virusImmunity, active
immunity, active - Venezuelan Equine Encephalitis Virus
- Western equine encephalitis virusImmunity, active
Western equine encephalitis virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03879603 | Phase 1 | Mar 29, 2019 | Battelle, Leidos, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), The EMMES Corporation |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Battelle | For profit | 1 | 0 | 1 | 2019 |
| Leidos | For profit | 1 | 0 | 1 | 2019 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2019 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2019 |
| The EMMES Corporation | For profit | 1 | 0 | 1 | 2019 |
5 organizations
Page 1 / 1